{"@id":"https://bioecon.ru/technology/exosome-therapies/","@type":"Technology","cluster":"regenerative-personalized","formats":{"html":"https://bioecon.ru/technology/exosome-therapies/","json":"https://bioecon.ru/api/v1/technology/exosome-therapies/index.json"},"id":"exosome-therapies","industries":["pharma","biomanufacturing"],"lang":"ru","links":{"industries":["https://bioecon.ru/industries/pharma/","https://bioecon.ru/industries/biomanufacturing/"],"suppliers":["https://bioecon.ru/companies/novartis/","https://bioecon.ru/companies/lonza-group/","https://bioecon.ru/companies/kheiron-biotech/","https://bioecon.ru/companies/astrazeneca/","https://bioecon.ru/companies/agc-biologics/","https://bioecon.ru/companies/impacfat/","https://bioecon.ru/companies/esco-aster/","https://bioecon.ru/companies/cryoport-systems/","https://bioecon.ru/companies/umami-bioworks/","https://bioecon.ru/companies/cellmeat/","https://bioecon.ru/companies/pbs-biotech/","https://bioecon.ru/companies/spiber-technologies-ab/"]},"maturity":7,"name":"Терапевтические экзосомы и внеклеточные везикулы","regions":["ch","eu","us","cn"],"risk":"medium","section":"technology","sector":"health-biomedicine","sources":[{"date":"2026-11-22","entity":"Swiss Biotech Directory 2026","kind":"vendor","urls":["https://www.swissbiotech.org/directory/"]}],"stages":[{"n":1,"title":"Перфузионный сбор везикул"},{"n":2,"title":"Тангенциальная ультрафильтрация"},{"n":3,"title":"Модификация поверхностных лигандов"},{"n":4,"title":"Регенераторный эффект in vivo"}],"summary":"Промышленное биопроизводство, ультрафильтрация и поверхностная модификация наноразмерных внеклеточных везикул (30–150 нм) из стволовых клеток для бесклеточной регенеративной терапии.","url":"/technology/exosome-therapies/","verified":"2026-11-22"}